FIRAPY Distributor Partnership
A Differentiated Opportunity in Dialysis Vascular Access Care
FIRAPY--Non-invasive far-infrared therapy
backed by more than two decades of dialysis-specific clinical evidence.
FIRAPY offers distributors an opportunity to go beyond conventional dialysis machines, consumables and vascular-access devices — and introduce a differentiated therapeutic approach to vascular-access care.
Why FIRAPY for Your Portfolio?
Compete Differently
Most dialysis portfolios compete in established categories such as dialysis machines, dialyzers, bloodlines, catheters and other consumables.
FIRAPY gives distributors something different: a non-invasive therapy for vascular-access care.
Differentiate Your Portfolio
Add a distinctive, evidence-based therapy beyond conventional dialysis equipment and consumables.
Open New Customer Conversations
Engage dialysis centers and nephrology teams around vascular-access care, not only equipment replacement or routine consumable purchasing.
Create New Tender Opportunities
Introduce a differentiated clinical category that may support new project and tender specifications
Build a Stronger Market Position
Develop a less commoditized product portfolio and strengthen your competitive position in the renal-care market.
Built on Clinical Evidence
FIRAPY is distinguished by an unusually extensive body of dialysis-specific clinical evidence accumulated over more than two decades
Guideline Recognition
FIRAPY-related clinical evidence has been referenced in international vascular-access guidelines, including KDOQI, ERBP and UK Kidney Association guidance.
40+ Peer-Reviewed Publications
Clinical and scientific research has investigated FIRAPY and far-infrared therapy across dialysis vascular access and related applications.
20+ Years of Clinical Experience
FIRAPY has accumulated more than two decades of clinical use and research experience.
2,000+ Dialysis Centers Worldwide
FIRAPY is used in more than 2,000 dialysis centers worldwide.
Clinical credibility that creates commercial opportunity.
Primiary Clinical Focus
Hemodialysis Vascular Access Care
Clinical studies have investigated FIRAPY in areas including:
- AVF maturation
- Vascular-access blood flow
- Long-term AVF patency
- Supportive vascular-access care during routine hemodialysis
FIRAPY provides a non-invasive, non-contact therapeutic approach that can complement conventional hemodialysis care.
Additional Clinical Applications.
FIRAPY's clinical and scientific development also extends beyond conventional vascular-access care
Limb Ischemia & Chronic Wound Care
Research has explored applications related to:
- Peripheral perfusion
- Collateral circulation
- Microcirculation
- Inflammatory and vascular responses
- Chronic wound-care related applications
Peritoneal Dialysis Care
Clinical research has also explored applications related to:
- Peritoneal function
- Peritoneal membrane health
- EPS-related applications
Territory Opportunities
Contact us any time
Tell us about your company and market
